|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01513 LIVZON PHARMA
Nominal 
26.350 -0.150 (-0.566%) Ranking Overview
Ranking based on 3 research report(s)
Average Ranking 2.67
|
Strong Buy (1)
0
|
Buy (2)
2
|
Hold (3)
0
|
Sell (4)
1
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | 210.00 RMB (cts) | |
| Net Profit | 1,953.65 RMB (MIL) | DPS | 135.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 2,130.00 | 228.00 | 164.10 | -- | 2,180.00 | 2,058.00 |
| 2025 | 2,283.00 | 244.00 | 180.61 | -- | 2,468.00 | 2,239.00 |
| 2026 | 2,483.00 | 268.00 | 197.52 | -- | 2,845.00 | 2,374.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 2,180.00 | 236.00 | 151.00 | HSBC | Buy | 34.00 | 19/09/2024 | |
| 2024 | 2,058.00 | 222.00 | -- | CITIC SEC | Buy | 32.00 | 28/10/2024 | |
| 2024 | 2,130.00 | 228.00 | 177.19 | MORGAN STANLEY | Underweight | 24.00 | 23/10/2024 | |
| 2025 | 2,468.00 | 267.00 | 171.00 | HSBC | -- | -- | 19/09/2024 | |
| 2025 | 2,239.00 | 242.00 | -- | CITIC SEC | -- | -- | 28/10/2024 | |
| 2025 | 2,283.00 | 244.00 | 190.22 | MORGAN STANLEY | -- | -- | 23/10/2024 | |
| 2026 | 2,845.00 | 308.00 | 197.00 | HSBC | -- | -- | 19/09/2024 | |
| 2026 | 2,483.00 | 268.00 | -- | CITIC SEC | -- | -- | 28/10/2024 | |
| 2026 | 2,374.00 | 254.00 | 198.04 | MORGAN STANLEY | -- | -- | 23/10/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 14/11/2024 15:04 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,170,971 |
| %Change | 3.208% |
| EPS / (LPS) | RMB 1.270 |
| NBV Per Share (¥) | RMB 15.027 |